4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Prodigiosin/AG-CN2-0105-M001/1 mg
商品详细Adipogen/Prodigiosin/AG-CN2-0105-M001/1 mg
Adipogen/Prodigiosin/AG-CN2-0105-M001/1 mg
Adipogen/Prodigiosin/AG-CN2-0105-M001/1 mg
商品编号: AG-CN2-0105-M001
品牌: Adipogen Inc
市场价: ¥4200.00
美元价: 2520.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsNSC47147;BRN4526727
ProductTypeChemical
Properties
FormulaC20H25N3O
MW323.4
MerckIndex14:7767
CAS82-89-3
Source/HostChemicalsIsolatedfromγ-proteobacteriumstrainMS-02-063.
PurityChemicals≥95%(HPLC)
AppearanceDarkredsolid.
SolubilitySolubleinmethanol,ethanol,chloroform,ethylacetate,hexane,acetoneoracetonitrile.Insolubleinwater.
DeclarationManufacturedbyBiOlinksK.K.withcourtesystrainfromTheKitasatoInstitute.
InChiKeySZXDNGVQRDTJSD-FOWTUZBSSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceProtectfromlight.
Use/StABIlityStableforatleast3yearsafterreceiptwhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Red-pigmentedantibiotic[1].
  • Antimalarial[2,13].
  • Immunosuppressive[3,7,11,12].
  • Apoptosisinducer[4-6,15].
  • Cytotoxic.Inducesphosphorylationofp38-MAPK[8].
  • Antimetastatic.Tumorinvasioninhibitor[9].
  • Inducesp21WAF1/CIP1expression[10].
  • Anticancercompound[11,12,15].
  • gp91(phox)andiNOSexpressioninhibitor[14].
  • mTORC1andmTORC2complexinhibitor[16].
  • Down-regulatesSKP2toinducep27(KIP1)stabilization[17].
ProductReferences
  1. TheAntibioticActivityofViolacein,Prodigiosin,andPhthiocol:H.C.Lichstein&V.F.VanDeSand;J.Bacteriol.52,145(1946)
  2. Antimalarialactivityofprodigiosin:A.J.Castro;Nature213,903(1967)
  3. T-cellspecificimmunosuppressionbyprodigiosinisolatedfromSerratiamarcescens:S.B.Han,etal.;Int.J.Immunopharmacol.20,1(1998)
  4. ProdigiosinfromthesupernatantofSerratiamarcescensinducesapoptosisinhaematopoieticcancercelllines:B.Montaner,etal.;Br.J.Pharmacol.131,585(2000)
  5. Prodigiosin-inducedapoptosisinhumancoloncancercells:B.Montaner&R.Perez-Tomas;LifeSci.68,2025(2001)
  6. ProdigiosininducescelldeathandmorphologicalchangesindicativeofapoptosisingastriccancercelllineHGT-1:C.Diaz-Ruiz,etal.;Histol.Histopathol.16,415(2001)
  7. ProdigiosinblocksTcellactivationbyinhibitinginterleukin-2Ralphaexpressionanddelaysprogressionofautoimmunediabetesandcollagen-inducedarthritis:S.B.Han,etal.;JPET299,415(2001)
  8. Thecytotoxicprodigiosininducesphosphorylationofp38-MAPKbutnotofSAPK/JNK:B.Montaner&R.Perez-Tomas;Toxicol.Lett.129,93(2002)
  9. Antimetastaticeffectofprodigiosinthroughinhibitionoftumorinvasion:J.Zhang,etal.;Biochem.Pharmacol.69,407(2005)
  10. Theanticanceragentprodigiosininducesp21WAF1/CIP1expressionviatransforminggrowthfactor-betareceptorpathway:V.Soto-Cerrato,etal.;Biochem.Pharmacol.74,1340(2007)
  11. Prodigiosinsasanticanceragents:livinguptotheirname:R.Pandey,etal.;Curr.Pharm.Des.15,732(2009)
  12. Newinsightsontheantitumoralpropertiesofprodiginines:R.Perez-Tomas&M.Vinas;Curr.Med.Chem.17,2222(2010)
  13. ProdigiosinproducedbySerratiamarcescensNMCC46asamosquitolarvicidalagentagainstAedesaegyptiandAnophelesstephensi:C.D.Patil,etal.;Parasitol.Res.109,1179(2011)
  14. Prodigiosininhibitsgp91(phox)andiNOSexpressiontoprotectmiceagainsttheoxidative/nitrosativebraininjuryinducedbyhypoxia-ischemia:C.C.Chang,etal.;Toxicol.Appl.Pharmacol.257,137(2011)
  15. Prodigiosin,theredpigmentofSerratiamarcescens,showscytotoxiceffectsandapoptosisinductioninHT-29andT47Dcancercelllines:D.Dalili,etal;Nat.Prod.Res.(Epubaheadofprint)(2011)
  16. IdentificationofdualmTORC1andmTORC2inhibitorsinmelanomacells:prodigiosinvs.obatoclax:M.Espona-Fiedler,etal.;Biochem.Pharmacol.83,489(2012)
  17. Prodigiosindown-regulatesSKP2toinducep27(KIP1)stabilizationandantiproliferationinhumanlungadenocarcinomacells:H.Y.Hsieh,etal.;Br.J.Pharmacol.166,2095 (2012)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。